SEEING INSIDE THE BOX

How Clinicians Can Use Contemporary Neuroscience Research in the Real World.

 

The following video series was sponsored by the ABCT Think Tank on Neuroscience:

Drs. Angela Fang and Sabine Wilhelm

MASSACHUSETTS GENERAL HOSPITAL

Introduction to the video series ‘Seeing Inside the Box: How Clinicians Can Use Contemporary Neuroscience Research in the Real World.’ Drs. Fang and Wilhelm discuss how neuroscience can address gaps in the field and provide a few examples of translational research that holds promise in improving clinical care.

Dr. Claire Gillan 

TRINITY COLLEGE, DUBLIN

Dr. Gillan describes her work on examining the basic mechanisms that give rise to mental disorders and how to define, diagnose, and treat mental illness. In particular, her work focuses on optimizing treatment allocation by measuring the vast individual differences among patients with the same diagnosis across multiple indicators of health and risk. 

Dr. Greg Siegle

UNIVERSITY OF PITTSBURGH, SCHOOL OF MEDICINE

Dr. Siegle discusses behavioral interventions that target brain mechanisms implicated in depression. In particular, Cognitive Control Training targets these presumed mechanisms and reduces rumination beyond therapy and medications, with sustained benefits during follow-up periods.

Dr. Tali Ball

STANFORD SCHOOL OF MEDICINE

Dr. Ball discusses using the neuroscience of fear extinction to improve exposure therapy for social anxiety.

Francesca Morfini

NORTHEASTERN UNIVERSITY

Ms. Morfini discusses using neuroimaging to identify diagnostic markers, develop novel therapeutic techniques, and predict treatment response for individuals with anxiety.

Drs. Simpson, van den Heuvel, & Gendanke Shavitt

COLUMBIA UNIVERSITY, AMSTERDAM UNIVERSITY, UNIVERSITY OF SAO PAULO

Drs. Simpson, van den Heuvel, & Gendanke Shavitt discuss their international collaboration to examine the neuroimaging signatures of OCD in relation to neurocognitive functioning and clinical profiles in a large multi-site study of patients with OCD and their siblings, and healthy volunteers. These bio-signatures may provide insights into how and when OCD develops and serve as targets for new treatments.

Dr. Robin Aupperle

LAUREATE INSTITUTE, UNIVERSITY OF TULSA

Dr. Aupperle discusses her work on understanding how therapies work and who they work for, and identifying novel targets of treatment. One project has found that neural responses during approach-avoidance conflict may be associated with responses to cognitive behavioral therapy.

Dr. Kym Young

UNIVERSITY OF PITTSBURGH, SCHOOL OF MEDICINE

Dr. Young discusses the neural mechanisms underlying major depressive disorder and the development of novel interventions, such as real-time fMRI neurofeedback, to target these mechanisms, which can be done in combination with cognitive behavioral therapy.

  • Grey Facebook Icon
  • Grey Twitter Icon

Contact us at: nttrsig@gmail.com

© 2018 by NTTR SIG